A detailed history of Ameritas Advisory Services, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 215 shares of EXAS stock, worth $14,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
215
Previous 277 22.38%
Holding current value
$14,411
Previous $14,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$40.91 - $56.0 $2,536 - $3,472
-62 Reduced 22.38%
215 $11,000
Q2 2025

Jul 21, 2025

BUY
$40.31 - $58.08 $11,165 - $16,088
277 New
277 $14,000
Q1 2023

Apr 28, 2023

BUY
$47.19 - $70.77 $22,415 - $33,615
475 New
475 $32,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.